Among hospitalized patients with COVID-19 in India, which is the most common extrapulmonary organ system affected during acute infection?

Explanation

## Extrapulmonary Manifestations of COVID-19 **Key Point:** Gastrointestinal involvement is the most common extrapulmonary manifestation in hospitalized COVID-19 patients, with diarrhea, nausea, vomiting, and abdominal pain reported in 30–40% of cases in Indian and global cohorts. ### Gastrointestinal Complications in COVID-19 **High-Yield:** The GI tract is affected through multiple mechanisms: 1. **Direct viral entry** — ACE2 and TMPRSS2 are highly expressed on enterocytes of the small intestine and colon, making the gut a primary target for SARS-CoV-2 2. **Gut dysbiosis** — viral infection disrupts the intestinal microbiome, contributing to diarrhea and malabsorption 3. **Inflammatory cytokines** — IL-6, TNF-α, and IL-1β cause intestinal epithelial injury and increased permeability 4. **Fecal-oral shedding** — viral RNA detected in stool even after nasopharyngeal clearance ### Types of GI Involvement | Complication | Frequency | Mechanism | Clinical Impact | |--------------|-----------|-----------|------------------| | **Diarrhea** | 20–40% | Enterocyte ACE2 invasion, dysbiosis | Most common GI symptom | | **Nausea/Vomiting** | 10–20% | Central and enteric nervous system involvement | Contributes to dehydration | | **Abdominal pain** | 5–15% | Mesenteric ischemia, enteritis | May mimic surgical abdomen | | **Elevated liver enzymes** | 15–30% | Hepatocyte ACE2 expression, drug toxicity | Usually transient | | **GI bleeding** | 1–5% | Mucosal injury, coagulopathy | Rare but serious | **Clinical Pearl:** GI symptoms may precede respiratory symptoms by 1–2 days and can be the sole presenting feature in a subset of patients. Stool PCR positivity persists longer than nasopharyngeal swabs, with implications for infection control. ### Why GI Is the Most Common Extrapulmonary System Affected - ACE2 expression in the gut is among the highest of any organ system - GI symptoms (diarrhea, nausea, abdominal pain) are reported in 30–40% of hospitalized patients in Indian cohorts (Indian J Med Res, 2020–2021) - Global meta-analyses (Lancet, JAMA) confirm GI involvement as the most prevalent extrapulmonary manifestation by symptom frequency - GI symptoms are present across mild, moderate, and severe disease categories ### Comparison with Other Organ Systems **Cardiovascular:** Troponin elevation (myocardial injury biomarker) occurs in 20–30% of severe cases, but clinically manifest myocarditis is rare (1–5%); overt thromboembolism occurs in 10–25% of ICU patients. The cardiovascular system is the most important prognostically, but not the most frequently affected clinically. **Renal:** Acute kidney injury occurs in 5–20% of hospitalized patients, predominantly in severe/ICU cases with hemodynamic compromise. **Neurological:** Encephalitis and Guillain-Barré syndrome are rare (<1% each); anosmia/ageusia (~30%) are common but represent cranial nerve I/VII involvement rather than central neurological disease. **Mnemonic:** **GI > CV > Renal > Neuro** — order of extrapulmonary clinical frequency in hospitalized COVID-19 patients. [cite: Indian J Med Res 2020; Lancet 2020; Harrison 21e Ch 297]